List of medicines under additional monitoring
List of medicines under additional monitoring
List of medicines under additional monitoring
Human medicines European public assessment report (EPAR): Jentadueto, linagliptin,metformin hydrochloride, Date of authorisation: 19/07/2012, Revision: 22, Status: Authorised
Human medicines European public assessment report (EPAR): Posaconazole AHCL, posaconazole, Date of authorisation: 25/07/2019, Revision: 7, Status: Authorised
Information and Q&A session on updated CAPs in web-based eAF, Online, European Medicines Agency, Amsterdam, the Netherlands, from 7 May 2024, 10:00 (CEST) to 7 May 2024, 11:00 (CEST)
Human medicines European public assessment report (EPAR): Posaconazole Accord, posaconazole, Date of authorisation: 25/07/2019, Revision: 9, Status: Authorised
Human medicines European public assessment report (EPAR): Lemtrada, alemtuzumab, Date of authorisation: 12/09/2013, Revision: 24, Status: Authorised
Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) meetings
Clinical Trials Information System (CTIS) Bitesize Talk: How to submit a transitional trial in CTIS, Online, Broadcast, from 29 February 2024, 16:30 (CET) to 29 February 2024, 18:00 (CET)
Human medicines European public assessment report (EPAR): Granupas (previously Para-aminosalicylic acid Lucane), para-aminosalicylic acid, Date of authorisation: 07/04/2014, Revision: 11, Status: Authorised
Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - April 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, from 23 April 2024, 09:00 (CEST) to 23 April 2024, 10:00 (CEST)